| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas. | J Natl Cancer Inst | 1998 | 5.30 |
| 2 | Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis. | Clin Cancer Res | 2001 | 2.28 |
| 3 | Long survival and therapeutic responses in patients with histologically disparate high-grade gliomas demonstrating chromosome 1p loss. | J Neurosurg | 2000 | 1.82 |
| 4 | Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas. | Int J Radiat Oncol Biol Phys | 2000 | 1.32 |
| 5 | PTEN is a target of chromosome 10q loss in anaplastic oligodendrogliomas and PTEN alterations are associated with poor prognosis. | Am J Pathol | 2001 | 1.04 |
| 6 | Inactivation of p53 sensitizes U87MG glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea. | Cancer Res | 2001 | 0.91 |
| 7 | The hPMS2 exon 5 mutation and malignant glioma. Case report. | J Neurosurg | 1999 | 0.75 |